KADENSA CAPITAL Ltd Has $12.19 Million Stock Holdings in Synopsys, Inc. $SNPS

Key Points

• KADENSA CAPITAL Ltd increased its holdings in Synopsys, Inc. by 1.7%, owning 28,427 shares valued at approximately $12.19 million as of the end of the most recent reporting period.
• Several institutional investors have significantly boosted their stakes in Synopsys, with Cornerstone Planning Group increasing its stake by 275%.
• CEO Sassine Ghazi sold over 11,000 shares of Synopsys stock, representing a 13.70% decrease in his ownership, as institutional investors hold 85.47% of the company's shares.

KADENSA CAPITAL Ltd lifted its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 1.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 28,427 shares of the semiconductor company's stock after buying an additional 478 shares during the period. KADENSA CAPITAL Ltd's holdings in Synopsys were worth $12,191,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Cornerstone Planning Group LLC grew its holdings in Synopsys by 275.0% during the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 44 shares during the last quarter. Saudi Central Bank acquired a new stake in Synopsys during the 1st quarter valued at $26,000. Clal Insurance Enterprises Holdings Ltd increased its holdings in shares of Synopsys by 441.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock valued at $28,000 after purchasing an additional 53 shares in the last quarter. Ameriflex Group Inc. acquired a new position in Synopsys during the 4th quarter valued at about $29,000. Finally, WPG Advisers LLC acquired a new stake in shares of Synopsys during the first quarter worth $34,000. Hedge funds and other institutional investors own 85.47% of the company's stock.

Insiders Place Their Bets

In other news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the completion of the transaction, the chief executive officer directly owned 71,615 shares in the company, valued at approximately $42,181,951.15. This represents a 13.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CRO Richard S. Mahoney sold 9,010 shares of the firm's stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total value of $4,245,602.10. Following the transaction, the executive directly owned 1,485 shares of the company's stock, valued at approximately $699,746.85. This represents a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by corporate insiders.

Synopsys Stock Performance

NASDAQ:SNPS traded down $3.82 on Friday, hitting $598.14. The company's stock had a trading volume of 1,388,613 shares, compared to its average volume of 1,007,890. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The stock has a fifty day moving average of $594.11 and a two-hundred day moving average of $506.20. The company has a current ratio of 7.02, a quick ratio of 6.85 and a debt-to-equity ratio of 1.01. The firm has a market capitalization of $92.81 billion, a P/E ratio of 43.19, a price-to-earnings-growth ratio of 3.93 and a beta of 1.14.

Analyst Ratings Changes

SNPS has been the subject of a number of research analyst reports. Rosenblatt Securities boosted their target price on Synopsys from $625.00 to $650.00 and gave the company a "buy" rating in a research note on Friday, July 25th. Wells Fargo & Company reissued a "positive" rating on shares of Synopsys in a research note on Wednesday, August 27th. The Goldman Sachs Group initiated coverage on Synopsys in a research note on Thursday, July 10th. They issued a "buy" rating and a $620.00 target price for the company. Piper Sandler upped their price objective on Synopsys from $615.00 to $660.00 and gave the stock an "overweight" rating in a research report on Monday, July 21st. Finally, Morgan Stanley reaffirmed an "overweight" rating and set a $715.00 price objective (up from $540.00) on shares of Synopsys in a research report on Monday, August 11th. Twelve research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $638.21.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.